Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 395JH | — |
Hiberix + only diluent given; Hiberix + only diluent given; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old female patient who received Hib (Hiberix) (batch number 395JH) for prophylaxis. On 15-JAN-2025, the patient received Hiberix. On 15-JAN-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix + only diluent given) and inappropriate dose of vaccine administered (Verbatim: Hiberix + only diluent given). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 22-JAN-2025 The nurse reported that the diluent portion of Hiberix vaccines was administered to a patient without the lyophilized component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility was the same as primary reporter.